| Literature DB >> 35276791 |
Ana Bayán-Bravo1,2, Jose Ramón Banegas1, Carolina Donat-Vargas1,3, Helena Sandoval-Insausti4, Manuel Gorostidi5, Fernando Rodríguez-Artalejo1,3, Pilar Guallar-Castillón1,3.
Abstract
BACKGROUND: Chronic kidney disease entails a high disease burden that is progressively increasing due to population aging. However, evidence on the effect of the Mediterranean diet on renal function is limited, in particular among older adults in Mediterranean countries.Entities:
Keywords: Mediterranean diet; a posteriori patterns; older adults; renal function decline
Mesh:
Year: 2022 PMID: 35276791 PMCID: PMC8839505 DOI: 10.3390/nu14030432
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Baseline characteristics of the Seniors-ENRICA participants according to renal function decline after 6.5 years of follow-up (2008/2010–2015) N = 975.
| Total | No Renal Function Decline | Renal Function Decline | ||
|---|---|---|---|---|
| N (%) | 975 (100) | 871 (89.3) | 104 (10.7) | |
| Sex, women, % | 48.6 | 49.7 | 39.4 | 0.047 |
| Age, in years, mean (SD) | 67.4 (5.43) | 67.2 (5.3) | 69.0 (6.1) | 0.014 |
| eGFR (SD) | 77.9 (12.2) | 78.2 (12.0) | 76.5 (14.2) | 0.189 |
| eGFR categories, % | ||||
| Category 1 (≥90) | 18.2 | 18.4 | 16.4 | 0.027 |
| Category 2 (≥60–89) | 74.2 | 74.4 | 72.1 | |
| Category 3a (≥45–59) | 6.8 | 6.5 | 8.7 | |
| Category 3b (≥30–44) | 0.8 | 0.7 | 1.9 | |
| Category 4 (≥15–29) | 0.1 | 0.0 | 1.0 | |
| Category 5 (<15) | 0 | 0 | 0 | |
| Serum creatinine | 0.90 (0.18) | 0.89 (0.17) | 0.93 (0.20) | 0.048 |
| Educational level, % | ||||
| Primary | 48.0 | 47.3 | 53.9 | 0.339 |
| Secondary | 26.7 | 27.3 | 21.1 | |
| University | 25.3 | 25.4 | 25.0 | |
| Energy intake in kcal, mean (SD) | 2046 (571) | 2054 (565) | 1974 (617) | 0.182 |
| Smoking status, % | ||||
| Never smoker | 56.6 | 57.2 | 51.9 | 0.032 |
| Former smoker | 31.9 | 32.3 | 28.9 | |
| Current smoker | 11.5 | 10.6 | 19.2 | |
| Alcohol consumption, % | ||||
| Habitual drinker | 47.5 | 48.5 | 39.4 | 0.244 |
| Occasional drinker | 21.4 | 21.4 | 22.1 | |
| Non-drinker | 23.6 | 22.7 | 30.8 | |
| Ex-drinker | 7.5 | 7.5 | 7.7 | |
| Leisure-time physical activity, MET-h/week, mean (SD) | 22.6 (15.7) | 22.9 (15.6) | 21.0 (16.2) | 0.075 |
| Household physical activity, MET-h/week, mean (SD) | 36.8 (31.6) | 37.5 (31.4) | 31.0 (32.5) | 0.049 |
| Time spent watching TV in h/week, mean (SD) | 17.4 (11.1) | 17.0 (10.8) | 20.1 (13.1) | 0.008 |
| Night sleeping time in h/day, mean (SD) | 7.14 (1.43) | 7.13 (1.43) | 7.20 (1.49) | 0.664 |
| Cardiovascular disease, % | 1.23 | 0.92 | 3.85 | 0.010 |
| Bronchitis or asthma, % | 7.7 | 7.8 | 6.7 | 0.697 |
| Cancer, % | 2.4 | 2.4 | 1.9 | 0.096 |
| Osteo-muscular disease, % | 46.7 | 46.0 | 51.9 | 0.256 |
| BMI at baseline in kg/m2, mean (SD) | 28.5 (4.16) | 28.5 (4.1) | 29.1 (4.6) | 0.119 |
| Metabolic syndrome components at baseline | ||||
| Glucose ≥ 100, % | 43.6 | 42.6 | 51.2 | 0.070 |
| Blood pressure ≥ 130/85, % | 80.7 | 80.6 | 81.7 | 0.782 |
| WC ≥ 102 men, ≥ 88 women, % | 56.3 | 55.3 | 64.4 | 0.078 |
| HDL-c < 40 men, < 50 women, % | 22.8 | 21.8 | 30.8 | 0.040 |
| Triglycerides ≥ 150, % | 20.9 | 19.9 | 29.8 | 0.018 |
| BMI in 2015 in kg/m2, mean (SD) | 27.9 (4.3) | 27.9 (4.2) | 28.6 (4.6) | 0.073 |
| Metabolic syndrome components in 2015 | ||||
| Glucose ≥ 100, % | 41.0 | 40.0 | 50.0 | 0.049 |
| Blood pressure ≥ 130/85, % | 66.7 | 65.8 | 74.0 | 0.092 |
| WC ≥ 102 men, ≥ 88 women, % | 59.4 | 58.7 | 65.4 | 0.187 |
| HDL-c < 40 men, < 50 women, % | 27.9 | 26.4 | 40.4 | 0.003 |
| Triglycerides ≥ 150, % | 16.5 | 15.7 | 23.1 | 0.056 |
| Muscle mass in kg, mean (SD) | 46.7 (9.4) | 46.6 (9.5) | 47.9 (9.1) | 0.197 |
SD (Standard Deviation); eGFR: estimated glomerular filtration rate (Stratification according to the Kidney Disease: Improving Global Outcomes KDIGO 2012). BMI: Body Mass Index, WC: waist circumference; HDL-c: High-density lipoprotein cholesterol. p values are based on chi-square test for qualitative variables or t-test for continuous variables.
Association between the adherence to the Mediterranean Diet Adherence Screener (MEDAS) index and the risk of renal function decline after 6.5-years of follow-up in the Seniors-ENRICA study (2008/2010–2015) N = 975.
| Renal Function Decline | Low Adherence to MEDAS | Moderate Adherence to MEDAS | High Adherence to MEDAS | |
|---|---|---|---|---|
| Cases/total | ||||
| Model 1 | Ref. | 0.78 (0.49–1.26) | 0.46 (0.26–0.83) † | 0.009 |
| Model 2 | Ref. | 0.67 (0.41–1.09) | 0.53 (0.29–0.95) * | 0.020 |
| Model 3 | Ref. | 0.63 (0.38–1.03) | 0.52 (0.29–0.95) * | 0.015 |
| Model 4 | Ref. | 0.61 (0.37–1.01) | 0.52 (0.28–0.94) * | 0.016 |
* p < 0.05; † p < 0.01. OR: Odds Ratio. CI: Confidence Interval. Model 1: Adjusted for sex, age, eGFR at baseline, education level (primary, secondary, or university), and total energy intake. Model 2: Additionally adjusted for smoking status (never, former, or current-smoker), alcohol consumption (habitual drinker, occasional drinker, non-drinker, or ex-drinker), leisure-time physical activity (MET-h/week), household physical activity (MET-h/week), occupational physical activity (sedentary, light, moderate/vigorous, or none), time spent watching TV (h/week), night sleeping time (h/day), prevalence of cardiovascular disease, bronchitis or asthma, cancer, and osteo-muscular disease. Model 3: Additionally adjusted for BMI at baseline and prevalent components of the metabolic syndrome (glucose ≥ 100 mg/dL (yes, no), blood pressure ≥ 130/85 mmHg (yes, no), abdominal obesity ≥ 102 cm in men and ≥ 88 cm in women (yes, no), HDL-c < 40 mg/dL in men and < 50 mg/dL in women (yes, no), triglycerides ≥ 150 mg/dL (yes, no). Model 4: Additionally adjusted for an increase in BMI (yes, no) and incident components of the metabolic syndrome developed during 2008/10 to 2015 (glucose ≥ 100 mg/dL (yes, no), blood pressure ≥ 130/85 mmHg (yes, no), abdominal obesity ≥ 102 cm in men and ≥ 88 cm in women (yes, no), HDL-c < 40 mg/dL in men and < 50 mg/dL in women (yes, no), triglycerides ≥ 150 mg/dL (yes, no), and muscular mass (kg).
Association between the adherence to a posteriori dietary patterns and the risk of renal function decline after 6.5-years of follow-up in the Seniors-ENRICA study (2008/2010–2015) N = 975.
| Western-Like Pattern | Mediterranean-Like Pattern | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Renal Function Decline | Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | Q3 | Q4 | ||
| Cases/total | ||||||||||
| Model 1 | 1 Ref. | 1.68 (0.91–3.09) | 1.61 (0.84–3.07) | 1.61 (0.76–3.42) | 0.235 | 1 Ref. | 0.68 (0.39–1.18) | 0.58 (0.32–1.04) | 0.40 (0.20–0.80) † | 0.008 |
| Model 2 | 1 Ref. | 1.60 (0.85–3.00) | 1.58 (0.81–3.08) | 1.42 (0.65–3.09) | 0.381 | 1 Ref. | 0.67 (0.38–1.18) | 0.63 (0.34–1.17) | 0.45 (0.22–0.92) * | 0.030 |
| Model 3 | 1 Ref. | 1.59 (0.85–2.98) | 1.50 (0.77–2.92) | 1.35 (0.61–2.97) | 0.474 | 1 Ref. | 0.67 (0.38–1.20) | 0.65 (0.35–1.19) | 0.47 (0.23–0.96) * | 0.042 |
| Model 4 | 1 Ref. | 1.65 (0.87–3.12) | 1.54 (0.78–3.05) | 1.43 (0.64–3.18) | 0.411 | 1 Ref. | 0.70 (0.39–1.24) | 0.68 (0.36–1.26) | 0.47 (0.23–0.97) * | 0.049 |
| Model 5 | 1 Ref. | 1.62 (0.86–3.07) | 1.37 (0.68–2.73) | 1.12 (0.49–2.57) | 0.798 | 1 Ref. | 0.68 (0.38–1.22) | 0.66 (0.35–1.25) | 0.45 (0.21–0.96) * | 0.070 |
* p < 0.05; † p < 0.01. OR: Odds Ratio. CI: Confidence Interval. Model 1: Adjusted for sex, age, eGFR at baseline, education level (primary, secondary, or university), and total energy intake. Model 2: Additionally adjusted for smoking status (never, former, or current-smoker), alcohol consumption (habitual drinker, occasional drinker, non-drinker, or ex-drinker), leisure-time physical activity (MET-h/week), household physical activity (MET-h/week), occupational physical activity (sedentary, light, moderate/vigorous, or none), time spent watching TV (h/week), night sleeping time (h/day), prevalence of cardiovascular disease, bronchitis or asthma, cancer, and osteo-muscular disease. Model 3: Additionally adjusted for BMI at baseline and prevalent components of the metabolic syndrome (glucose ≥ 100 mg/dL (yes, no), blood pressure ≥ 130/85 mmHg (yes, no), abdominal obesity ≥ 102 cm in men and ≥ 88 cm in women (yes, no), HDL-c < 40 mg/dL in men and < 50 mg/dL in women (yes, no), triglycerides ≥ 150 mg/dL (yes, no). Model 4: Additionally adjusted for an increase in BMI (yes, no) and incident components of the metabolic syndrome developed during 2008/10 to 2015 (glucose ≥100 mg/dL (yes, no), blood pressure ≥ 130/85 mmHg (yes, no), abdominal obesity ≥ 102 cm in men and ≥ 88 cm in women (yes, no), HDL-c < 40 mg/dL in men and < 50 mg/dL in women (yes, no), triglycerides ≥ 150 mg/dL (yes, no), and muscular mass (kg). Model 5: Additionally adjusted for the other a posteriori dietary pattern, as appropriate.